Clinical Trials Browser

Phase 3 × Laryngeal Diseases × Docetaxel × Clear all

NCT03340896 2025-09-02

SALTORL

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases